Splice variants in apoptotic pathway.

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• Apoptosis, or programmed cell death, is a fundamental biological process for removing superfluous or mutated somatic cells.
• Deregulation of apoptotic signaling pathways is a hallmark of oncogenesis.
• Alternative pre-messenger RNA (mRNA) splicing generates diverse mRNA and protein isoforms, contributing to genomic and functional diversity.

Purpose of the Study:

• To review splice variants of key apoptotic genes.
• To explore the regulatory mechanisms of alternative splicing in these genes.
• To highlight the potential of targeting splice variants and splicing machinery in cancer therapy.

Main Methods:

• Literature review of apoptosis and alternative splicing.
• Summary of splice variants for BCL2L1, BIRC5, CFLAR, and MADD.
• Discussion of regulatory mechanisms governing alternative splicing of apoptotic genes.

Main Results:

• Several apoptotic genes, including BCL2L1, BIRC5, CFLAR, and MADD, are subject to alternative pre-mRNA splicing.
• These splice variants can function as critical pro-apoptotic or anti-apoptotic factors.
• Understanding aberrant splicing in malignancies is key to developing targeted therapies.

Conclusions:

• Alternative splicing plays a significant role in regulating apoptotic gene function.
• Targeting specific splice variants or the splicing machinery itself presents a promising avenue for cancer treatment.
• Integrating knowledge of apoptosis and aberrant splicing can lead to novel therapeutic strategies.